All In Biotech

Drug Trial Radar · NCT03768349

PSMA and C-11 Choline PET in Patients With Biochemical Recurrence of Prostate Cancer

Last checked: Nov 20, 2026Latest source record: Apr 6, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

250

Actual

Start

Jan 3, 2019

Primary completion

Jul 21, 2021

Study completion Jul 21, 2021

Sponsor

Lead sponsor
Mayo ClinicAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Dec 7, 2018

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Early phase 1
Allocation
Non randomized
Model
Parallel
Masking
None
Primary purpose
Diagnostic
FDA-regulated drug
Yes
Who can join
Male only, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Imaging and staging of prostate cancer is critical for surgical and treatment planning. In this protocol we will image patients with suspected metastatic prostate cancer using 11C-Choline PET and Gallium-68 labeled HBED-CC PSMA (more commonly called 68Ga-PSMA-11) or F-18 labeled PSMA 1007 in order to demonstrate their utility in detecting prostate cancer.

Conditions

  • Prostate Cancer

Interventions

  • Ga-68 PSMA11Drug

    Ga-68 PSMA11 PET/CT for detection of tumor location

  • F-18 PSMA 1007Drug

    F-18 PSMA 1007 PET/CT for detection of tumor location

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Tumor Detection on PET/CTTime frame: 12 Months post PET/CT

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Mayo Clinic

    Rochester, Minnesota

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.